Top 25 issuers by reported market capitalization in The Weekly 250. Prices: 2 Oct 2026 close. Changes: versus 2026-09-25; not live.
Reference snapshot
Financial centers · Natural Earth
Currency cross-rates show local-currency units per U.S. dollar, calculated from the same ECB euro reference snapshot. The U.S. card leads with a dated S&P500 index close and shows USD per EUR beneath. Pins locate financial centers; currency references are not exchange-specific prices.
Choose a region with the arrow keys, then use the Market selector. Policy settings and equity-index levels retain their own dates. Shading shows the selected region, not market performance.
All observations, definitions & sources →DEALS • LISTINGS • PRIVATE MARKETS • OVERSIGHT
The week in reporting and analysis. September 28–October 4, 2026.
M&A + Buy/Sell Signaling
USD per common equivalent
Sources: [3] Lifecore: Agreement with Webster Equity Partners · 2026-09-28
World Labs agreement and a contingent healthcare buyout show why deal terms matter as much as headline values.
Read the report →Private Market Offerings
USD billions principal
Sources: [1] Snowflake: Upsized $3.75 billion convertible pricing · 2026-09-29
Snowflake prices a larger convertible deal as an SEC pre-IPO fund complaint highlights the distance between an underlying company and the investor’s actual claim.
Read the report →IPO's
Accelevation’s $540 million offering combines fresh capital with shareholder sales; smaller European and Asian deals broaden the picture.
Read the report →Antitrust & Financial Oversight
Illustration
Sources: [1] FTC and states announce proposed Corteva pesticide settlement · 2026-09-28; [3] DOJ statement of interest in meatpacking-worker litigation · 2026-09-29
Pesticide distribution, hotel pricing and adviser referrals put contracts and incentives at the center of the week’s oversight news.
Read the report →